Comment: Increased risk for type 2 diabetes in spinal cord injury
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The prevalence of diabetes is increasing globally, with an estimated 371 million individuals affected globally and 4.8 million people who died due to diabetes in 2012.1 Type 2 diabetes accounts for at least 90% of all cases of diabetes, and the number of people with type 2 diabetes is increasing in every country.1 Abnormalities of carbohydrate and lipid metabolism are more common among people in the spinal cord injury (SCI) population than in the able-bodied population.2 There is increased morbidity and mortality due to type 2 diabetes in SCI.
Footnotes
Disclosures: The author reports no disclosures. Go to Neurology.org for full disclosures.
- Received August 15, 2013.
- Accepted in final form August 21, 2013.
- © 2013 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Spinal cord injury and type 2 diabetesResults from a population health surveyJacquelyn J. Cragg, Vanessa K. Noonan, Marcel Dvorak et al.Neurology, October 23, 2013 -
Article
Noncommunicable disease among adults with cerebral palsyA matched cohort studyJennifer M. Ryan, Mark D. Peterson, Anthony Matthews et al.Neurology, August 28, 2019 -
Article
Type 2 diabetes mellitus, brain atrophy, and cognitive declineChris Moran, Richard Beare, Wei Wang et al.Neurology, January 23, 2019 -
Articles
Aggregation of vascular risk factors and risk of incident Alzheimer diseaseJ. A. Luchsinger, C. Reitz, L. S. Honig et al.Neurology, August 22, 2005


